BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31816436)

  • 1. Association of aspirin therapy with risk of hepatocellular carcinoma: A systematic review and dose-response analysis of cohort studies with 2.5 million participants.
    Wang S; Yu Y; Ryan PM; Dang M; Clark C; Kontogiannis V; Rahmani J; Varkaneh HK; Salehisahlabadi A; Day AS; Zhang Y
    Pharmacol Res; 2020 Jan; 151():104585. PubMed ID: 31816436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin for the prevention of hepatocellular carcinoma: an updated meta-analysis with particular focus on patients with chronic liver disease.
    Yi M; Feng X; Peng W; Teng F; Tang Y; Chen Z
    Eur J Clin Pharmacol; 2022 Apr; 78(4):647-656. PubMed ID: 35032181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review with meta-analysis: The effects of non-steroidal anti-inflammatory drugs and anti-platelet therapy on the incidence and recurrence of hepatocellular carcinoma.
    Tan RZH; Lockart I; Abdel Shaheed C; Danta M
    Aliment Pharmacol Ther; 2021 Aug; 54(4):356-367. PubMed ID: 34247393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
    Lee TY; Hsu YC; Tseng HC; Yu SH; Lin JT; Wu MS; Wu CY
    JAMA Intern Med; 2019 May; 179(5):633-640. PubMed ID: 30882847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin Use and Risk of Hepatocellular Carcinoma in a National Cohort Study of Korean Adults.
    Hwang IC; Chang J; Kim K; Park SM
    Sci Rep; 2018 Mar; 8(1):4968. PubMed ID: 29563592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does aspirin reduce the incidence, recurrence, and mortality of hepatocellular carcinoma? A GRADE-assessed systematic review and dose-response meta-analysis.
    Ma S; Qu G; Sun C; Liu H; Jiang Y; Li N; Wu B; Gao J; Feng L; Xie P; Xia W; Kim NH; Lowe S; Bentley R; Zhu Y; Zhou Q; Sun Y
    Eur J Clin Pharmacol; 2023 Jan; 79(1):39-61. PubMed ID: 36334108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of aspirin and nonaspirin NSAIDs therapy with the incidence risk of hepatocellular carcinoma: a systematic review and meta-analysis on cohort studies.
    Liu Y; Ren T; Xu X; Jin J
    Eur J Cancer Prev; 2022 Jan; 31(1):35-43. PubMed ID: 33470689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse Association of Coffee with Liver Cancer Development: An Updated Systematic Review and Meta-analysis.
    Bhurwal A; Rattan P; Yoshitake S; Pioppo L; Reja D; Dellatore P; Rustgi V
    J Gastrointestin Liver Dis; 2020 Sep; 29(3):421-428. PubMed ID: 32830818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Aspirin Use and Risk of Hepatocellular Carcinoma.
    Simon TG; Ma Y; Ludvigsson JF; Chong DQ; Giovannucci EL; Fuchs CS; Meyerhardt JA; Corey KE; Chung RT; Zhang X; Chan AT
    JAMA Oncol; 2018 Dec; 4(12):1683-1690. PubMed ID: 30286235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regular Aspirin Use Is Associated with a Reduced Risk of Hepatocellular Carcinoma (HCC) in Chronic Liver Disease: a Systematic Review and Meta-analysis.
    Tan JL; Sidhu-Brar S; Woodman R; Chinnaratha MA
    J Gastrointest Cancer; 2023 Jun; 54(2):325-331. PubMed ID: 35717551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin and aspirin for prevention of hepatocellular carcinoma: what are the levels of evidence?
    Carrat F
    Clin Res Hepatol Gastroenterol; 2014 Feb; 38(1):9-11. PubMed ID: 24183917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin Use Is Associated with a Reduced Incidence of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
    Memel ZN; Arvind A; Moninuola O; Philpotts L; Chung RT; Corey KE; Simon TG
    Hepatol Commun; 2021 Jan; 5(1):133-143. PubMed ID: 33437907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin Use and the Risk of Hepatocellular Carcinoma: A Meta-analysis.
    Wang Y; Wang M; Liu C; Wang W; Shi J; Dang S
    J Clin Gastroenterol; 2022 Aug; 56(7):e293-e302. PubMed ID: 35316225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project.
    Petrick JL; Sahasrabuddhe VV; Chan AT; Alavanja MC; Beane-Freeman LE; Buring JE; Chen J; Chong DQ; Freedman ND; Fuchs CS; Gaziano JM; Giovannucci E; Graubard BI; Hollenbeck AR; Hou L; Jacobs EJ; King LY; Koshiol J; Lee IM; Linet MS; Palmer JR; Purdue MP; Rosenberg L; Schairer C; Sesso HD; Sigurdson AJ; Wactawski-Wende J; Zeleniuch-Jacquotte A; Campbell PT; McGlynn KA
    Cancer Prev Res (Phila); 2015 Dec; 8(12):1156-62. PubMed ID: 26391917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study.
    Liao YH; Hsu RJ; Wang TH; Wu CT; Huang SY; Hsu CY; Su YC; Hsu WL; Liu DW
    BMC Gastroenterol; 2020 Jan; 20(1):6. PubMed ID: 31918672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin in the prevention of hepatocellular carcinoma in diabetic patients: A systematic review.
    Cunha V; Cotrim HP; Rocha R; Carvalho K; Lins-Kusterer L
    Ann Hepatol; 2020; 19(3):232-237. PubMed ID: 31836424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between aspirin consumption and hepatocellular carcinoma: a systematic review and meta-analysis.
    Wang S; Zuo L; Lin Z; Yang Z; Chen R; Xu Y
    Eur J Med Res; 2023 Jul; 28(1):226. PubMed ID: 37422691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose-response meta-analysis.
    Kennedy OJ; Roderick P; Buchanan R; Fallowfield JA; Hayes PC; Parkes J
    BMJ Open; 2017 May; 7(5):e013739. PubMed ID: 28490552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective serotonin reuptake inhibitor use and the risk of hepatocellular carcinoma: a systematic review and dose-response analysis of cohort studies with one million participants.
    Bhagavathula AS; Woolf B; Rahmani J; Vidyasagar K; Tesfaye W
    Eur J Clin Pharmacol; 2022 Apr; 78(4):547-555. PubMed ID: 35039907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection.
    Tsan YT; Lee CH; Wang JD; Chen PC
    J Clin Oncol; 2012 Feb; 30(6):623-30. PubMed ID: 22271485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.